Total Funding
84
50
Total FundingPost-IPO Debt raised
Growth Score
-5 pts
Heat Score
-4 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
See more interactive data and historical milestones on desktop for the best experience
184212
Valeo Pharma is a pharmaceutical company dedicated to bringing prescription products to the market.
- Richard J. MacKay: Chairman
- Luc Mainville: Senior VP & CFO
About the Company
Valeo Pharma is devoted to providing healthcare professionals and patients with the highest quality specialty products and healthcare solutions. Valeo Pharma concentrates on the commercialization of specialized innovative products addressing the needs of patients suffering from complicated or rare diseases. The company's focus on
respiratory/allergy, ophthalmology, and hospital specialty products demonstrates its dedication to providing vital healthcare solutions.
